| 1 |
33468383 | Predictive value of KRAS mutation and excision repair cross-complementing 1 (ERCC1) protein overexpression in patients with colorectal cancer administered FOLFOX regimen. | 2021 May |
2 |
| 2 |
31815582 | Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201. | 2020 Feb 10 |
1 |
| 3 |
32118594 | Prognostic and Predictive Role of Excision Repair Cross-complementation Group 1 and Thymidylate Synthase in Colorectal Carcinoma Patients Received FOLFOX Chemotherapy: An Immunohistochemical Study. | 2020 Nov/Dec |
1 |
| 4 |
28608017 | Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy. | 2017 Nov |
2 |
| 5 |
26083491 | ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer. | 2015 |
1 |
| 6 |
26161376 | ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting. | 2015 Jun |
3 |
| 7 |
24318989 | Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy. | 2014 Apr |
2 |
| 8 |
24847383 | ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy. | 2014 |
1 |
| 9 |
23996617 | Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy. | 2013 Dec |
2 |
| 10 |
24125975 | Excision repair cross-complementation group 1 codon 118 polymorphism, micro ribonucleic acid and protein expression, clinical outcome of the advanced gastric cancer response to first-line FOLFOX-4 in Qinghai-Tibetan plateau population. | 2013 Jul-Sep |
1 |
| 11 |
23169295 | Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer. | 2012 Dec 4 |
1 |
| 12 |
21057378 | Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy. | 2011 Jan |
1 |
| 13 |
22214010 | [Predictive marker for the efficacy of FOLFOX treatment in colon cancer (TS, ERCC1 etc)]. | 2011 Apr |
1 |
| 14 |
19068092 | ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma. | 2009 Feb |
2 |